Showing results (1231-1240 of 8,885) with videos related to

Sort By:
Pageof 889
European Urology|December 18, 2007
Core biopsies of renal tumors: a study on diagnostic accuracy, interobserver, and intraobserver variabilityIntan Kümmerlin, Fiebo ten Kate, Frank Smedts, et al.
European Urology|December 18, 2007
The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancerSigurdur Gudjónsson, Björn L Isfoss, Kerstin Hansson, et al.
European Urology|June 3, 2008
Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in ratsYao-Chi Chuang, Naoki Yoshimura, Chao-Cheng Huang, et al.
European Urology|February 8, 2014
Plasmakinetic enucleation of the prostate compared with open prostatectomy for prostates larger than 100 grams: a randomized noninferiority controlled trial with long-term results at 6 yearsShushang Chen, Lingfeng Zhu, Jinquan Cai, et al.
European Urology|February 4, 2014
Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional studySteven Joniau, Alberto Briganti, Paolo Gontero, et al.
European Urology|May 31, 2008
Good outcome for patients with few lymph node metastases after radical retropubic prostatectomyMartin C Schumacher, Fiona C Burkhard, George N Thalmann, et al.
European Urology|January 23, 2025
Prevalence, Diagnosis, and Management of Stress Urinary Incontinence in Women: A Collaborative ReviewLisa Moris, John Heesakkers, Victor Nitti, et al.
European Urology|January 22, 2025
Intravesical Instillation of Chemotherapy Before Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: The REBACARE TrialThomas van Doeveren, Sebastiaan Remmers, Egbert R Boevé, et al.
European Urology|February 4, 2025
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell CarcinomaJens Bedke, Yasmin Abu Ghanem, Laurence Albiges, et al.
European Urology|January 30, 2025
Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 TrialJohann S de Bono, Meng He, Zhen Shi, et al.
Pageof 889